U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H7NO
Molecular Weight 85.1045
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PYRROLIDONE

SMILES

O=C1CCCN1

InChI

InChIKey=HNJBEVLQSNELDL-UHFFFAOYSA-N
InChI=1S/C4H7NO/c6-4-2-1-3-5-4/h1-3H2,(H,5,6)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin.
2001 May
Transdermal delivery of physostigmine: effects of enhancers and pressure-sensitive adhesives.
2002 Aug
Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure. Effects of the quaternization of the basic nitrogen on the interaction with 5-HT(3) receptor.
2002 Aug
Palladium-catalyzed aminoallylation of activated olefins with allylic halides and phthalimide.
2002 Aug 23
Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
2002 Aug 5
A new tin-free source of amidyl radicals.
2002 Aug 8
GABA and glutamate in the human brain.
2002 Dec
Design of inhibitors of scytalone dehydratase: probing interactions with an asparagine carboxamide.
2002 Dec
Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
2002 Dec 13
Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.
2002 Dec 2
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid.
2002 Jun 17
Regional differences in expression of VEGF mRNA in rat gastrocnemius following 1 hr exercise or electrical stimulation.
2002 Jun 19
Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard.
2002 Mar
Interaction of influenza A virus M1 matrix protein with caspases.
2002 May
[Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
2002 May-Jun
Enantioselective Michael additions of nitromethane by a catalytic double activation method using chiral lewis Acid and achiral amine catalysts.
2002 Nov 13
Nefiracetam induces a long-lasting facilitation of hippocampal postsynaptic responses in mice lacking the NMDA receptor epsilon1 subunit.
2002 Nov 22
Influence of storage time and temperature on the stability of indomethacin Pluronic F-127 gels.
2002 Oct
N-Arylated pyrrolidin-2-ones and morpholin-3-ones as potassium channel openers.
2002 Oct
Geographic variation of natural products of tropical nudibranch Asteronotus cespitosus.
2002 Sep
Evaluation of solid dispersions of Clofazimine.
2002 Sep
Radical carboazidation of alkenes: an efficient tool for the preparation of pyrrolidinone derivatives.
2002 Sep 16
Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride.
2003 Apr
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint.
2003 Dec 15
A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer.
2003 Feb
[Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone].
2003 Jan-Feb
Source reduction for prevention of methylene chloride hazards: cases from four industrial sectors.
2003 Jul 21
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.
2003 Jul 3
Pyroglutamyl-peptidase I: cloning, sequencing, and characterisation of the recombinant human enzyme.
2003 Mar
A theoretical study on the complete catalytic cycle of the hetero-Pauson-Khand-type [2+2+1] cycloaddition reaction of ketimines, carbon monoxide and ethylene catalyzed by iron carbonyl complexes.
2003 Mar 3
Dichloroketene-chiral olefin-based approach to pyrrolizidines: highly stereocontrolled synthesis of (+)-amphorogynine A.
2003 May 15
Pyrrolidonyl and pyridyl alkaloids in Lymantria dispar.
2003 Nov-Dec
A general treatment of solubility. 1. The QSPR correlation of solvation free energies of single solutes in series of solvents.
2003 Nov-Dec
Complex formation of protein with different water-soluble synthetic polymers.
2003 Nov-Dec
Evaluation of critical formulation factors in the development of a rapidly dispersing captopril oral dosage form.
2003 Oct
Formation of vinylogous compounds in model Maillard reaction systems.
2003 Oct
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.
2003 Oct
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase.
2003 Oct 1
Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing.
2003 Oct 2
Dioxygen-coupled oxidative amination of styrene.
2003 Oct 29
Chemical and olfactory characterization of odorous compounds and their precursors in the parotoid gland secretion of the green tree frog, Litoria caerulea.
2003 Sep
Vibrational and electronic couplings in ultraviolet resonance Raman spectra of cyclic peptides.
2003 Sep
2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
2003 Sep
1-[2-(4-nitrophenoxy)acetyl]pyrrolidin-2-one: an antiamnesic agent.
2003 Sep
2-pyrrolidinone induces a long-lasting facilitation of hippocampal synaptic transmission by enhancing alpha7 ACh receptor responses via a PKC pathway.
2003 Sep 10
Properties and biocompatibility of polypropylene graft copolymer films.
2004 Feb 15
CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
2004 Jan
Vitrification of bovine oocytes and its application to intergeneric somatic cell nucleus transfer.
2004 Jan 1
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
2004 Jan 29
Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism.
2004 Jan 8
Patents
Name Type Language
PYRROLIDONE
MART.  
Systematic Name English
POVIDONE IMPURITY B [EP IMPURITY]
Common Name English
COPOVIDONE IMPURITY A [EP IMPURITY]
Common Name English
GAMMA-AMINOBUTYROLACTAM
Systematic Name English
PYRROLIDONE [MART.]
Common Name English
2-PYRROLIDONE [MI]
Common Name English
2-TETRAHYDROPYRROLONE
Systematic Name English
PYRROLID-2-ONE
Systematic Name English
NSC-4593
Code English
PYRROLIDONE [EP MONOGRAPH]
Common Name English
2-PYRROLIDONE
HSDB   MI  
Systematic Name English
FEMA NO. 4829
Code English
BUTYROLACTAM
Systematic Name English
2-PYRROLIDONE [HSDB]
Common Name English
.ALPHA.-PYRROLIDONE
Common Name English
NSC-8413
Code English
2-PYRROLIDINONE
Systematic Name English
Code System Code Type Description
CHEBI
36592
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
EPA CompTox
DTXSID8027246
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
PUBCHEM
12025
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
HSDB
2652
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
CAS
616-45-5
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
ECHA (EC/EINECS)
210-483-1
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
NSC
4593
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
MESH
C028537
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
WIKIPEDIA
2-PYRROLIDONE
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
FDA UNII
KKL5D39EOL
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
RXCUI
1358473
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m9400
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY Merck Index
SMS_ID
100000129573
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
EVMPD
SUB39495
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
DAILYMED
KKL5D39EOL
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY
NSC
8413
Created by admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
PRIMARY